Clinical trials
Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Completed | 5 |
| Active, not recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Therapeutic Advances in Childhood Leukemia Consortium | 3 |
| AstraZeneca | 2 |
| Accenture | 1 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| Children's Oncology Group | 1 |
| Imviva Bio | 1 |
| PedAL BCU, LLC | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 17 |
| Leukemia, Myeloid, Acute | 4 |
| Recurrence | 4 |
| Myelodysplastic Syndromes | 3 |
| Burkitt Lymphoma | 2 |
| Hodgkin Disease | 2 |
| Leukemia | 2 |
| Leukemia, Biphenotypic, Acute | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.